by Priya Shetty
A free trade agreement with the EU threatens India’s generic drug industry and the developing world’s access to lifesaving drugs, says Priya Shetty.
In global health circles India has been dubbed ‘the world’s pharmacy’. It supplies a huge share of lifesaving drugs to the developing world, largely because of provisions in the country’s intellectual property laws that allow local companies to produce and export cheap generic drugs.
Science and Development Network for more